| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BRISTOL MYERS SQUIBB CO | EVP, Chief Research Officer | Common Stock, $0.10 par value | 21,528 | $1,308,256 | $60.77 | 10 Mar 2026 | Direct |
| BRISTOL MYERS SQUIBB CO | EVP, Chief Research Officer | Market Share Units | 17,959 | $1,241,609 | $52.99 | 10 Mar 2026 | Direct |
| BRISTOL MYERS SQUIBB CO | EVP, Chief Research Officer | Common Stock, $0.10 par value | 3,026 | $183,913 | $60.77 | 10 Mar 2026 | BMS Savings and Investment Program |
| BRISTOL MYERS SQUIBB CO | EVP, Chief Research Officer | Common Stock, $0.10 par value | 200 | $12,154 | $60.77 | 10 Mar 2026 | Family Trust |
| BRISTOL MYERS SQUIBB CO | EVP, Chief Research Officer | Performance Shares | 26,939 | 10 Mar 2026 | Direct | ||
| Translate Bio, Inc. | Director | Stock Option (right to buy) | 0 | 14 Sep 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BMY | BRISTOL MYERS SQUIBB CO | 10 Mar 2026 | 14 | $0 | 4 | EVP, Chief Research Officer | 12 Mar 2026, 16:20 |
| BMY | BRISTOL MYERS SQUIBB CO | 10 Mar 2025 | 18 | -$227,827 | 4 | EVP, Chief Research Officer | 12 Mar 2025, 21:39 |
| BMY | BRISTOL MYERS SQUIBB CO | 10 Mar 2024 | 16 | -$105,697 | 4 | EVP, Chief Research Officer | 12 Mar 2024, 21:21 |
| BMY | BRISTOL MYERS SQUIBB CO | 02 Dec 2023 | 3 | -$13,727 | 4 | EVP, Chief Research Officer | 05 Dec 2023, 18:23 |
| BMY | BRISTOL MYERS SQUIBB CO | 03 Aug 2023 | 1 | -$44,754 | 4 | EVP, Chief Research Officer | 07 Aug 2023, 17:24 |
| BMY | BRISTOL MYERS SQUIBB CO | 03 Jul 2023 | 0 | $0 | 3 | EVP, Chief Research Officer | 05 Jul 2023, 21:34 |
| /report/000120919121056055-plenge-robert-m-2021-09-14 | Translate Bio, Inc. | 14 Sep 2021 | 4 | $0 | 4 | Director | 14 Sep 2021, 19:28 |
| /report/000120919121040986-plenge-robert-m-2021-06-16 | Translate Bio, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 17:16 |